![Quiver Logo](/static/img/logo-icon.png)
![ACHL logo](https://quiver-logos.s3.us-east-2.amazonaws.com/achl.png)
Achilles Therapeutics plc American Depositary Shares
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACHL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of ACHL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ACHL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to ACHL
Recent picks made for ACHL stock on CNBC
ETFs with the largest estimated holdings in ACHL
Flights by private jets registered to ACHL
![Quiver Logo](/static/img/logo-icon.png)